October 22nd 2019EP. 1: Definition, Diagnosis, and Progression of Psoriasis
October 22nd 2019EP. 2: Association Between Psoriasis, PsA and Metabolic Syndrome
October 22nd 2019EP. 3: Prevalence and Burden of Psoriasis and Metabolic Syndrome
October 22nd 2019EP. 4: Monitoring for Psoriasis Comorbidities and Associated Complications
October 22nd 2019EP. 5: Standard of Care and Guidelines for Psoriasis
October 22nd 2019EP. 6: Identifying the Differing Mechanisms of Available Biologics
October 22nd 2019EP. 7: Patient Preferences and Payer Approval of Treatment
October 22nd 2019EP. 8: Comorbidities and Changes in Treatment Plan
October 22nd 2019EP. 9: Decreased Efficacy, PASI Score vs BSA, and Nonresponders
October 22nd 2019EP. 10: IL-23: Long-term Data and Safety Data
October 22nd 2019EP. 11: Improving Patient Adherence
October 22nd 2019EP. 12: Dosing Impact on Patient Adherence and Patient Preference
October 22nd 2019EP. 13: Understanding Plan B vs Plan D Coverage
October 22nd 2019EP. 14: Studies of Biologics on Cardiovascular Outcomes and Cost
October 22nd 2019EP. 15: Treatment Landscape and Final Thoughts
